Pretraga
Rezultati
Analysis of factors with impact on duration of hospitalisation for patients operated for breast cancer during COVID 19 pandemic [2022]
Maksimovic, Z; Curcic, A; Ljubisavljevic, R; Zarev, I; Simovic, I; Misic, M; Mitrovic, S; Mihajlovic, Z; Bursac, S; Vukasinovic, J;
Kosic, D; Maljevac, E; Bihorac, Dzemil; Vatricevic, S; Babic, Z; Rsovac, N; Azanjac, A; Aleksandrovic, D; Tanasijevic, Jasminka B; Kostic, N;
Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America [2016]
Karalexi, Maria A; ...; Zivkovic, Snezana V; ...; (broj, koautora 24)A randomized phase II study investigating cilengitide added to standard chemoradiotherapy in patients with newly diagnosed glioblastoma with unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Initial report of the CORE study [2013]
Nabors, Louis Burt; Fink, Karen L; Mikkelsen, Tom; Grujicic, Danica M; Tarnawski, Rafal; Nam, Do-Hyun; Perry, James R; Mazurkiewicz, Maria; Picard, Martin; Reardon, David AIncreasing number of melanoma in situ in Serbia due to media campaign - experience of melanoma center [2013]
Nikolić, AleksandraGanetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels (Meeting Abstract) [2013]
Zarić, Bojan137 Antitumor activities of some macrofungi extracts
[2014]
Zizak, Z. The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change [2024]
Singer, Susanne; ...; Krejovic-Trivic, Sanja B; ...; (broj, koautora 31)XRCC1 Arg399Gln polymorphism and susceptibility for hereditary BRCA1/2 negative breast cancer in Serbian women [2014]
Krivokuca, Ana M2854 Sentinel lymph node biopsy in medullary thyroid carcinomas - A pilot study
[2015]
Džodić, Radan Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial [2023]
Holmes Frankie A; Moy Beverly; Delaloge Suzette; Chia Stephen KL; Ejlertsen Bent; Mansi Janine; Iwata Hiroji; Gnant Michael; Buyse Marc; Barrios Carlos H;Filters
By type
- 160